These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 25136948)

  • 1. Pertussis: still a cause of death, seven decades into vaccination.
    Jakinovich A; Sood SK
    Curr Opin Pediatr; 2014 Oct; 26(5):597-604. PubMed ID: 25136948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The decline and resurgence of pertussis in the US.
    Rohani P; Drake JM
    Epidemics; 2011 Sep; 3(3-4):183-8. PubMed ID: 22094341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pertussis in the Era of New Strains of Bordetella pertussis.
    Souder E; Long SS
    Infect Dis Clin North Am; 2015 Dec; 29(4):699-713. PubMed ID: 26337739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of acellular pertussis vaccine in Japan, evaluated by 23 years of its use for routine immunization.
    Kuno-Sakai H; Kimura M
    Pediatr Int; 2004 Dec; 46(6):650-5. PubMed ID: 15660862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Old problems and new strategies in the fight against pertussis].
    Carlino C; Zaratti L; Franco E
    Ig Sanita Pubbl; 2013; 69(4):473-80. PubMed ID: 24091847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-cell and acellular pertussis vaccination programs and rates of pertussis among infants and young children.
    Vickers D; Ross AG; Mainar-Jaime RC; Neudorf C; Shah S
    CMAJ; 2006 Nov; 175(10):1213-7. PubMed ID: 17098950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost of epidemiological transition: a study of a decrease in pertussis vaccination coverage.
    Girard DZ
    Health Policy; 2005 Nov; 74(3):287-303. PubMed ID: 15951048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New pertussis vaccination approaches: en route to protect newborns?
    Locht C; Mielcarek N
    FEMS Immunol Med Microbiol; 2012 Nov; 66(2):121-33. PubMed ID: 22574832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Licensed pertussis vaccines in the United States. History and current state.
    Klein NP
    Hum Vaccin Immunother; 2014; 10(9):2684-90. PubMed ID: 25483496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Australian vaccine preventable disease epidemiological review series: pertussis, 2006-2012.
    Pillsbury A; Quinn HE; McIntyre PB
    Commun Dis Intell Q Rep; 2014 Sep; 38(3):E179-94. PubMed ID: 25391404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations to control pertussis prioritized relative to economies: A Global Pertussis Initiative update.
    Forsyth KD; Tan T; von König CW; Heininger U; Chitkara AJ; Plotkin S
    Vaccine; 2018 Nov; 36(48):7270-7275. PubMed ID: 30337176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pertussis before and after the introduction of acellular pertussis vaccines in Finland.
    Elomaa A; He Q; Minh NN; Mertsola J
    Vaccine; 2009 Sep; 27(40):5443-9. PubMed ID: 19628060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak.
    Witt MA; Katz PH; Witt DJ
    Clin Infect Dis; 2012 Jun; 54(12):1730-5. PubMed ID: 22423127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US cohort.
    Witt MA; Arias L; Katz PH; Truong ET; Witt DJ
    Clin Infect Dis; 2013 May; 56(9):1248-54. PubMed ID: 23487373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of maternal pertussis vaccination in England: an observational study.
    Amirthalingam G; Andrews N; Campbell H; Ribeiro S; Kara E; Donegan K; Fry NK; Miller E; Ramsay M
    Lancet; 2014 Oct; 384(9953):1521-8. PubMed ID: 25037990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in Canada.
    Bettinger JA; Halperin SA; De Serres G; Scheifele DW; Tam T
    Pediatr Infect Dis J; 2007 Jan; 26(1):31-5. PubMed ID: 17195702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling the effect of changes in vaccine effectiveness and transmission contact rates on pertussis epidemiology.
    Pesco P; Bergero P; Fabricius G; Hozbor D
    Epidemics; 2014 Jun; 7():13-21. PubMed ID: 24928665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and effectiveness of acellular pertussis vaccines: a 20-year Swedish experience.
    Hallander HO; Gustafsson L
    Expert Rev Vaccines; 2009 Oct; 8(10):1303-7. PubMed ID: 19803750
    [No Abstract]   [Full Text] [Related]  

  • 19. Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine: recent epidemiology.
    Sheridan SL; Frith K; Snelling TL; Grimwood K; McIntyre PB; Lambert SB
    Expert Rev Vaccines; 2014 Sep; 13(9):1081-106. PubMed ID: 25093268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shift in the epidemiology of pertussis infection: an indication for pertussis vaccine boosters for adults?
    Yeh SH; Mink CM
    Drugs; 2006; 66(6):731-41. PubMed ID: 16706548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.